Ali Arif Nasir 13D/13G Filings for Entero Therapeutics, Inc. (ENTO)

Ali Arif Nasir 13D and 13G filings for Entero Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-06-10
9:30 pm
Sale
2025-06-0613DENTERO THERAPEUTICS INC
ENTO
Ali Arif Nasir76,967
4.900%
-6,666decrease
(-7.97%)
Filing
2025-06-09
9:55 pm
Purchase
2025-06-0213DENTERO THERAPEUTICS INC
ENTO
Ali Arif Nasir83,633
5.300%
83,633increase
(New Position)
Filing